(Q73318762)

English

Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia

scientific article published on 01 January 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia: the Israel National Study report (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

3

object named as

G Rechavi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

B Stark

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R Sharon

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

D Attias

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Ballin

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G Cividalli

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Y Burstein

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

D Sthoeger

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Abramov

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R Zaizov

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

0 references

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

88

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

205-216

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Brain sarcoma of meningeal origin after cranial irradiation in childhood acute lymphocytic leukemia. Case report.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukaemia treated with cranial irradiation.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Long-term sequelae of cancer treatment on the central nervous system in childhood

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: a ten-year follow-up

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Central nervous system leukemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

CNS chemoradiotherapy of childhood leukemia: the plot thickens but the ending bodes well

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Methotrexate infusions in poor prognosis acute lymphoblastic leukemia in children: I. The Norwegian methotrexate study in acute lymphoblastic leukemia in childhood, August 1975-December 1980

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Sex differences in prognosis for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Ital

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Cerebrospinal fluid drug levels of leukemic children receiving intravenous 5 g/m2 methotrexate.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Methotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Evidence for CSF accumulation of 5-methyltetrahydrofolate during repeated courses of methotrexate plus folinic acid rescue

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Neuropsychologic effects of chemotherapy on children with cancer: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Studies of cerebral blood flow in children with acute lymphoblastic leukemia: case reports of six children treated with methotrexate examined by single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Secondary acute myelogenous leukemia following safe exposure to etoposide

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Primitive neuroectodermal tumor of bone as a second malignant neoplasm in a child previously treated for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Increase in topoisomerase-II-mediated DNA breaks and cytotoxicity of VP16 in human U937 lymphoma cells pretreated with low doses of methotrexate

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C205%3A%3AAID-CNCR28%3E3.0.CO%3B2-7

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(20000101)88:1<205::AID-CNCR28>3.0.CO;2-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618625%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73318762&oldid=1758643854"